Open | $0.419 |
Close | $0.407 |
Volume / Avg. | 168.569K / 57.059K |
Day Range | 0.370 - 0.419 |
52 Wk Range | 0.400 - 43.820 |
Market Cap | $3.699M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | % |
Days to Cover | 2.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biophytis (NASDAQ: BPTS) through any online brokerage.
Other companies in Biophytis’s space includes: Virios Therapeutics (NASDAQ:VIRI), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Biophytis (NASDAQ: BPTS) was reported by HC Wainwright & Co. on Wednesday, August 16, 2023. The analyst firm set a price target for 15.00 expecting BPTS to rise to within 12 months (a possible 3847.37% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biophytis (NASDAQ: BPTS) is $0.38 last updated March 18, 2024 at 4:42 PM EDT.
There are no upcoming dividends for Biophytis.
Biophytis’s FY earnings are confirmed for Tuesday, April 16, 2024.
There is no upcoming split for Biophytis.
Biophytis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.